|
For Immediate Release |
10 June 2010 |
ImmuPharma PLC
Annual Report and Accounts
Notice of Annual General Meeting : 17 June 2010
In accordance with Rule 20 of the AIM Rules, ImmuPharma PLC (AIM:IMM), the specialist drug discovery and development company, confirms that the Annual Report and Accounts for the year ended 31 December 2009, has been posted to shareholders.
The annual report is available, in electronic form, for download on the Company's website www.immupharma.com.
The Company's Annual General Meeting will be held on 17 June 2010 at 11am at 50 Broadway, London, SW1H 0BL.
- Ends -
For further information please contact:
|
ImmuPharma PLC: |
|
|
Dimitri Dimitriou, Chief Executive Officer |
+44 20 7152 4080 |
|
Richard Warr, Chairman |
+44 20 7152 4080 |
|
Buchanan Communications |
+ 44 20 7466 5000 |
|
Lisa Baderoon |
www.buchanan.uk.com |
|
Catherine Breen |
|
|
George Prassas |
|
|
Panmure Gordon & Co |
|
|
Andrew Burnett |
+44 151 243 0963 |
|
Rakesh Sharma |
This information is provided by RNS